IL158342A0 - Methods and means for use of hla-dq restricted t-cell receptors and hla-dq-binding prolamine-derived peptides - Google Patents
Methods and means for use of hla-dq restricted t-cell receptors and hla-dq-binding prolamine-derived peptidesInfo
- Publication number
- IL158342A0 IL158342A0 IL15834202A IL15834202A IL158342A0 IL 158342 A0 IL158342 A0 IL 158342A0 IL 15834202 A IL15834202 A IL 15834202A IL 15834202 A IL15834202 A IL 15834202A IL 158342 A0 IL158342 A0 IL 158342A0
- Authority
- IL
- Israel
- Prior art keywords
- hla
- prolamine
- restricted
- binding
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/7051—T-cell receptor (TcR)-CD3 complex
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Botany (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Pulmonology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01201377 | 2001-04-12 | ||
EP01204383 | 2001-11-16 | ||
PCT/NL2002/000235 WO2002083722A2 (en) | 2001-04-12 | 2002-04-11 | Methods and means for use of hla-dq restricted t-cell receptors and hla-dq-binding prolamine-derived peptides |
Publications (1)
Publication Number | Publication Date |
---|---|
IL158342A0 true IL158342A0 (en) | 2004-05-12 |
Family
ID=26076879
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15834202A IL158342A0 (en) | 2001-04-12 | 2002-04-11 | Methods and means for use of hla-dq restricted t-cell receptors and hla-dq-binding prolamine-derived peptides |
Country Status (7)
Country | Link |
---|---|
US (1) | US20040241161A1 (xx) |
EP (1) | EP1377604B1 (xx) |
CA (1) | CA2443886A1 (xx) |
IL (1) | IL158342A0 (xx) |
MX (1) | MXPA03009313A (xx) |
NO (1) | NO20034588L (xx) |
WO (1) | WO2002083722A2 (xx) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9923306D0 (en) | 1999-10-01 | 1999-12-08 | Isis Innovation | Diagnostic and therapeutic epitope, and transgenic plant |
AU2003215272B2 (en) * | 2002-02-14 | 2008-04-03 | The Board Of Trustees Of The Leland Stanford Junior University | Enzyme treatment of foodstuffs for celiac sprue |
US8143210B2 (en) | 2002-02-14 | 2012-03-27 | The Board Of Trustees Of The Leland Stanford Junior University | Enzyme treatment of foodstuffs for celiac sprue |
GB0212885D0 (en) * | 2002-06-05 | 2002-07-17 | Isis Innovation | Therapeutic epitopes and uses thereof |
DK1563300T3 (da) | 2002-11-20 | 2012-07-23 | Univ Leland Stanford Junior | Diagnostisk fremgangsmåde til cøliaki |
AU2005237287B2 (en) | 2004-04-28 | 2011-08-11 | Btg International Limited | Epitopes related to coeliac disease |
US10105437B2 (en) | 2004-04-28 | 2018-10-23 | Btg International Limited | Epitopes related to coeliac disease |
AU2011247868B2 (en) * | 2004-04-28 | 2014-05-22 | Btg International Limited | Epitopes related to coeliac disease |
EP1612558A1 (en) * | 2004-06-30 | 2006-01-04 | Academisch Ziekenhuis Leiden | Method for detecting gluten |
US8092794B2 (en) * | 2006-03-15 | 2012-01-10 | Isocell Pharma S.A. | Pharmaceutical compositions comprising SODs and prolamine based peptide fragments |
WO2008090126A1 (de) * | 2007-01-22 | 2008-07-31 | N-Zyme Biotec Gmbh | Getränke für zöliakiepatienten und gluten/gliadin-sensitive personen und verfahren zur herstellung |
EP2659901B1 (en) * | 2008-04-21 | 2015-01-21 | Bio-Rad Laboratories, Inc. | Recombinant deamidated gliadin antigen |
EP2367561B1 (en) | 2008-11-30 | 2015-05-20 | Immusant, Inc. | Compositions and methods for treatment of celiac disease |
FR2942409B1 (fr) * | 2009-02-20 | 2013-07-26 | Natacha Voillot | Composition pharmaceutique pour la prevention des avortements a repetition. |
EP2673292A4 (en) * | 2011-02-08 | 2014-05-21 | Phadia Ab | WHEAT ANTIGENES AND PEPTIDES FOR DIAGNOSIS OF WHEAT SENSITIVITY |
CN104254777B (zh) | 2011-12-05 | 2016-08-24 | 伯乐实验室公司 | 重组脱酰胺化麦醇溶蛋白抗原 |
CA2923822A1 (en) | 2013-09-10 | 2015-03-19 | Immusant, Inc. | Dosage of a gluten peptide composition |
AU2015323979A1 (en) | 2014-09-29 | 2017-05-18 | Immusant, Inc. | Use of HLA genetic status to assess or select treatment of celiac disease |
EP3585818A4 (en) * | 2017-02-27 | 2020-12-23 | Chugai Seiyaku Kabushiki Kaisha | ANTI-HLA-DQ2.5 / 8 ANTIBODIES AND ITS USE FOR THE TREATMENT OF C LIATIC DISEASE |
PE20231208A1 (es) | 2020-09-18 | 2023-08-17 | Chugai Pharmaceutical Co Ltd | Anticuerpo anti antigenos de leucocitos humanos (hla) isoforma dq2.5 y su uso para el tratamiento de la enfermedad celiaca |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0905518A1 (en) * | 1997-09-23 | 1999-03-31 | Academisch Ziekenhuis Leiden | Peptides specific for gluten-sensitive T-cells and use thereof |
US7214786B2 (en) * | 2000-12-14 | 2007-05-08 | Kovalic David K | Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
-
2002
- 2002-04-11 IL IL15834202A patent/IL158342A0/xx unknown
- 2002-04-11 MX MXPA03009313A patent/MXPA03009313A/es not_active Application Discontinuation
- 2002-04-11 EP EP02722972.3A patent/EP1377604B1/en not_active Expired - Lifetime
- 2002-04-11 US US10/474,955 patent/US20040241161A1/en not_active Abandoned
- 2002-04-11 WO PCT/NL2002/000235 patent/WO2002083722A2/en not_active Application Discontinuation
- 2002-04-11 CA CA002443886A patent/CA2443886A1/en not_active Abandoned
-
2003
- 2003-10-13 NO NO20034588A patent/NO20034588L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1377604A2 (en) | 2004-01-07 |
NO20034588L (no) | 2003-12-10 |
MXPA03009313A (es) | 2004-11-12 |
WO2002083722A3 (en) | 2003-02-06 |
NO20034588D0 (no) | 2003-10-13 |
EP1377604B1 (en) | 2014-12-31 |
CA2443886A1 (en) | 2002-10-24 |
US20040241161A1 (en) | 2004-12-02 |
WO2002083722A2 (en) | 2002-10-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL158342A0 (en) | Methods and means for use of hla-dq restricted t-cell receptors and hla-dq-binding prolamine-derived peptides | |
EP1420796A4 (en) | ANDROGEN RECEPTOR MODULATORS AND METHODS OF USE | |
PL363322A1 (en) | Combination therapy using anti-egfr antibodies and anti-hormonal agents | |
EP1423120A4 (en) | 2H-PHTALAZINE-1-ONES AND METHODS OF USE THEREOF | |
IL160001A0 (en) | Peptide based multimeric targeted contrast agents and methods for the preparation thereof | |
EP1391212A4 (en) | ORAL PREPARATIONS AND MEDIA FOR ORAL PREPARATIONS | |
AU2002254224A1 (en) | Apparatus and methods for capture of medical agents | |
EP1416884A4 (en) | DISTRIBUTION OF AGENTS WITH THERAPEUTIC PROPERTIES | |
EP1377232A4 (en) | OCULAR DEVICES FOR DELIVERY OF THERAPEUTIC AGENT AND METHODS OF MAKING AND USING SUCH DEVICES | |
AU5716901A (en) | G protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same | |
PL365780A1 (en) | Promyostatin peptides and methods of using same | |
EP1372739A4 (en) | STABILIZED THERAPEUTIC AND IMAGING AGENTS | |
HUP0401863A3 (en) | Amino acid-copolymers for suppression of autoimmune diseases, and methods of use | |
AU2002364699A8 (en) | Receptors and membrane-associated proteins | |
EP1501352A4 (en) | METHOD AND COMPOSITIONS FOR PROTRACTED ACTIVE SUBSTANCE | |
EP1406631A4 (en) | DOPAMINE RECEPTOR LIGANDS AND CORRESPONDING THERAPEUTIC METHODS | |
AU2002309970A8 (en) | Receptors and membrane-associated proteins | |
AU2003222225A8 (en) | Receptors and membrane-associated proteins | |
GB0325624D0 (en) | Use of microparticles for antigen delivery | |
AU2002326910A1 (en) | Receptors and membrane-associated proteins | |
AU2002253716A1 (en) | Methods and means for use of hla-dq restricted t-cell receptors and hla-dq-binding prolamine-derived peptides | |
AU2002360790A8 (en) | Compositions and methods for the therapeutic use of an atonal-associated sequence for a gastrointestinal condition | |
EP1315737A4 (en) | ORTHOLOGY OF HUMAN RECIPES AND USE METHOD | |
CA98995S (en) | Base portion of an air-purifying device | |
EP1406921A4 (en) | HYPOGLYCAEMIC PEPTIDES AND METHOD FOR USE THEREOF |